EU's CHMP adopted positive opinion recommending granting of marketing authorisation for Fylrevy (10740.00Ft, +130.00)
Hikma Pharmaceuticals announces launch of Enoby and Xtrenbo in the US (1549.0000p, -21)
Hikma Pharmaceuticals and Gedeon Richter receive FDA approval for denosumab biosimilars Enoby and Xtrenbo (1644.0000p, 0)
Mayne Pharma Group notes Australian government approves NEXTSTELLIS for Pharmaceutical Benefits Scheme reimbursement (A$5.16, 0.00)
RBC Capital Markets transfers ALM.SM, BIOA.B.SS, FYB.GR, others
Mayne Pharma Group confirms the FDA Untitled Letter does not impact its ability to sell and distribute NEXTSTELLIS in the United States (A$5.93, -0.86)
EU's CHMP adopted a positive opinion recommending the granting of a marketing authorisation for Gedeon Richter's Junod (10860.00Ft, 0.00)
EU's CHMP adopted a positive opinion recommending the granting of a marketing authorisation for Yaxwer (10870.00Ft, 0.00)
Gedeon Richter upgraded to buy from hold at HSBC, we're told (timing uncertain) (10340.00Ft, +250.00)
AbbVie and Gedeon Richter announce new collaboration for the discovery and development of novel targets for neuropsychiatric conditions ($189.71, +1.83)
Powered by FactSet Research Systems Inc.